![Joseph Miller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Miller
Director of Finance/CFO at
LB PHARMACEUTICALS INC
Net worth: 9 M $ as of 2026-09-29
Profile
Mr. Joseph M.
Miller, CPA, is a Chief Financial Officer at LB Pharmaceuticals, Inc. Mr. Miller was previously employed as a Chief Financial & Accounting Officer by Aurinia Pharmaceuticals, Inc., a Vice President-Finance by Sucampo Pharmaceuticals LLC, a Senior Director-Accounting by Qiagen Genomics, Inc., a Senior Director-Accounting by QIAGEN NV, a Chief Financial Officer & Vice President-Finance by Eppendorf Real Estate Corp., and a Chief Financial Officer & Vice President-Finance by Eppendorf-5 Prime, Inc. He also served on the board at Avalo Therapeutics, Inc. He received his undergraduate degree from Villanova University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-01 | 576,421 ( 0.43% ) | 9 M $ | 2026-09-29 |
Joseph Miller active positions
| Companies | Position | Start |
|---|---|---|
| LB PHARMACEUTICALS INC | Director of Finance/CFO | 2026-09-01 |
Former positions of Joseph Miller
| Companies | Position | End |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Director of Finance/CFO | 2026-03-19 |
| AVALO THERAPEUTICS, INC. | Director of Finance/CFO | 2020-04-23 |
| SUCAMPO PHARMACEUTICALS, INC. | Director of Finance/CFO | 2018-03-31 |
Qiagen Genomics, Inc.
 Qiagen Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and technology in the bioscience area | Comptroller/Controller/Auditor | 2014-12-31 |
| QIAGEN N.V. | Comptroller/Controller/Auditor | 2014-12-31 |
Education of Joseph Miller
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
62
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
QIAGEN NV
 QIAGEN NV Medical SpecialtiesHealth Technology Manufactures and distributes sample and assay technology products for pre-analytical sample preparations | Health Technology |
Eppendorf, Inc.
 Eppendorf, Inc. BiotechnologyHealth Technology Manufactures bio-tech products | Health Technology |
Qiagen Genomics, Inc.
Qiagen Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and technology in the bioscience area | Commercial Services |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sucampo Pharmaceuticals LLC
 Sucampo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures prostone based pharmaceuticals products | Health Technology |
Eppendorf-5 Prime, Inc. | |
Avalo Therapeutics, Inc.
 Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
LB Pharmaceuticals, Inc.
 LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression and neuropsychiatric diseases | Health Technology |
- Stock Market
- Insiders
- Joseph Miller
